HUP0000476A3 - Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states - Google Patents
Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease statesInfo
- Publication number
- HUP0000476A3 HUP0000476A3 HU0000476A HUP0000476A HUP0000476A3 HU P0000476 A3 HUP0000476 A3 HU P0000476A3 HU 0000476 A HU0000476 A HU 0000476A HU P0000476 A HUP0000476 A HU P0000476A HU P0000476 A3 HUP0000476 A3 HU P0000476A3
- Authority
- HU
- Hungary
- Prior art keywords
- betha
- dihydroequilenin
- treatment
- pharmaceutical compositions
- free radical
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003254 radicals Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76306596A | 1996-12-10 | 1996-12-10 | |
| PCT/US1997/022153 WO1998025625A1 (en) | 1996-12-10 | 1997-12-05 | USE OF 17β-DIHYDROEQUILENIN AS AN ANTIOXIDANT |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0000476A2 HUP0000476A2 (en) | 2000-10-28 |
| HUP0000476A3 true HUP0000476A3 (en) | 2001-01-29 |
Family
ID=25066793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0000476A HUP0000476A3 (en) | 1996-12-10 | 1997-12-05 | Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0944390A1 (en) |
| JP (1) | JP2001506627A (en) |
| KR (1) | KR20000069400A (en) |
| CN (1) | CN1239891A (en) |
| AR (1) | AR010343A1 (en) |
| AU (1) | AU744098C (en) |
| BR (1) | BR9713998A (en) |
| CA (1) | CA2272074A1 (en) |
| HU (1) | HUP0000476A3 (en) |
| IL (1) | IL130070A0 (en) |
| TW (1) | TW422693B (en) |
| WO (1) | WO1998025625A1 (en) |
| ZA (1) | ZA9711054B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030013692A1 (en) * | 2001-01-19 | 2003-01-16 | Gullans Steven R. | Methods of treating neurological disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4154820A (en) * | 1976-02-23 | 1979-05-15 | Akzona Incorporated | Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers |
| IL107343A (en) * | 1992-11-02 | 2003-10-31 | Wyeth Corp | PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN |
| US5545635A (en) * | 1995-05-23 | 1996-08-13 | Eli Lilly And Company | Inhibiting bone loss with equilenin |
| AU7013296A (en) * | 1995-08-30 | 1997-03-19 | Eli Lilly And Company | N-butylsulfonate esters of estrogens |
-
1997
- 1997-11-27 TW TW086117837A patent/TW422693B/en not_active IP Right Cessation
- 1997-12-05 CA CA002272074A patent/CA2272074A1/en not_active Abandoned
- 1997-12-05 WO PCT/US1997/022153 patent/WO1998025625A1/en not_active Application Discontinuation
- 1997-12-05 JP JP52680398A patent/JP2001506627A/en not_active Ceased
- 1997-12-05 HU HU0000476A patent/HUP0000476A3/en unknown
- 1997-12-05 CN CN97180447A patent/CN1239891A/en active Pending
- 1997-12-05 IL IL13007097A patent/IL130070A0/en unknown
- 1997-12-05 KR KR1019997005152A patent/KR20000069400A/en not_active Application Discontinuation
- 1997-12-05 EP EP97949738A patent/EP0944390A1/en not_active Withdrawn
- 1997-12-05 AU AU78452/98A patent/AU744098C/en not_active Ceased
- 1997-12-05 BR BR9713998-0A patent/BR9713998A/en not_active IP Right Cessation
- 1997-12-09 ZA ZA9711054A patent/ZA9711054B/en unknown
- 1997-12-09 AR ARP970105777A patent/AR010343A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001506627A (en) | 2001-05-22 |
| AR010343A1 (en) | 2000-06-07 |
| IL130070A0 (en) | 2000-02-29 |
| EP0944390A1 (en) | 1999-09-29 |
| AU744098C (en) | 2003-07-31 |
| AU7845298A (en) | 1998-07-03 |
| CA2272074A1 (en) | 1998-06-18 |
| AU744098B2 (en) | 2002-02-14 |
| HUP0000476A2 (en) | 2000-10-28 |
| KR20000069400A (en) | 2000-11-25 |
| TW422693B (en) | 2001-02-21 |
| CN1239891A (en) | 1999-12-29 |
| BR9713998A (en) | 2000-02-29 |
| WO1998025625A1 (en) | 1998-06-18 |
| ZA9711054B (en) | 1999-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL121170A0 (en) | Compositions for the treatment of dermatological disorders | |
| IL125735A0 (en) | Pharmaceutical compositions for the treatment of glaucoma | |
| HUP9903489A3 (en) | Use of epinastine for the preparation of pharmaceutical compositions treating pain | |
| HUP0103654A2 (en) | Use of smilagenin and anzurogenin-d for production of pharmaceutical compositions for the treatment of alzheimer's disease | |
| EP0808324A4 (en) | Compositions and methods for the treatment and diagnosis of cardiovascular disease | |
| SG122738A1 (en) | Compositions and methods for the prevention and diagnosis of lyme disease | |
| IL86423A0 (en) | Pharmaceutical compositions for the treatment of alzheimer's disease | |
| IL127146A0 (en) | Transdermal propentofylline compositions for the treatment of alzheimer's disease | |
| IL117656A0 (en) | Pharmaceutical compositions for the treatment of travellers diarrhea | |
| HUP9904317A3 (en) | Use of 1-hydroxy-2-pyridones for producing pharmaceutical compositions suitable for the treatment of skin diseases | |
| IL117695A0 (en) | Pharmaceutical agents for the treatment of alzheimer's disease | |
| HUP0004331A3 (en) | Use of phanquinone for producing pharmaceutical compositions for the treatment of alzheimer's disease and combined pharmaceutical compositions containing it | |
| IL117655A0 (en) | Pharmaceutical compositions for the treatment of travellers diarrhea | |
| IL121096A0 (en) | Pharmaceutical compositions for the treatment of liver disease | |
| HUP9900309A3 (en) | Use of ridogrel for producing pharmaceutical compositions for the treatment of inflammatory bowel diseases | |
| HUP9901247A3 (en) | Use of naphthimidazole-, naphthoxazole- and naphthothiazole-diones for the preparation of pharmaceutical compositions treating diseases caused by vascular function deficiency | |
| IL113057A0 (en) | Compositions for the treatment of dandruff | |
| GB9510162D0 (en) | Compositions for the treatment of skin conditions | |
| ZA914435B (en) | Treatment of disease | |
| HUP0000569A3 (en) | Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
| HUP0000570A3 (en) | Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
| IL120005A0 (en) | Pharmaceutical compositions for the treatment of the eye | |
| EP0755262A4 (en) | Composition for the treatment of lung disease | |
| HUP0000476A3 (en) | Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states | |
| ITRM940806A0 (en) | PREPARATION FOR THE TREATMENT OF OBESITY |